Data Driven Methods for Kinase Drug Design

webinar

Thu, 27 Apr 2023, 16:00 CEST (Berlin)

Prof. Dr. Andrea Volkamer, Saarland University, Germany

Data Driven Methods for Kinase Drug Design

Human protein kinases are involved in several diseases which turned them into an important class for targeted therapy. To date there are almost 6,000 kinase structures in the PDB and around 70 small molecule kinase inhibitors available. Still several challenges remain related to drug promiscuity, resistance, and untapped kinase territory.

In this BioSolveIT webinar, Andrea will summarize the portfolio of methods which either use the openly available kinase data to generate new knowledge, or enable the community to engage in this data more easily. Using the TeachOpenCADD platform, she will demonstrate how to orchestrate diverse CADD tasks for individual kinases. Furthermore, Andrea’s lab developed freely available tools supporting diverse tasks: (i) KinFragLib for fragment based kinase inhibitor design, (ii) KiSSim – a KLIFS-based kinase structural similarity fingerprint, and (iii) a pipeline to assess kinase similarity from different data perspectives. All examples make use of the OpenCADD-KLIFS module to facilitate the integration of KLIFS data into kinase research workflows.

Andrea will close with further ongoing projects in structure-informed ML for kinase polypharmacology (openkinome).

Join us for an exciting talk and a vivid discussion.

Current news

category
Software
SeeSAR 13: ‘Midas’ — Tangible Merit
May 15, 2023 09:58 CEST
Enter the next stage of modern and sophisticated drug discovery with SeeSAR ‘Midas’. Version 13 has been developed as a powerful and user-friendly tool for the generation of goal-oriented results — with a single click! Midas comes with a novel ideation engine that we call ‘MedChemesis’: A ligand mutation tool...
Read on
category
Software
April 2023 Update of Enamine's REAL Space
April 28, 2023 15:31 CEST
We are proud to share the latest update of Enamine’s REAL Space. The version comes with an additional set of over 300 million novel compounds approaching 37 billion of commercially available compounds. Enamine excels in delivering your compounds of interest within few weeks with noteworthy purity. One of the key...
Read on
A Chat with BioSolvers from the States — Challenges and Opportunities
April 17, 2023 14:04 CEST
Drug discovery is slowly but steadily transforming. A key factor contributing to that is the evolution of computational drug discovery solutions in the past decade that are now an integral part of all stages of research and development. Yet, novel methods and innovations in general come with their own challenges...
Read on